<DOC>
	<DOCNO>NCT00503490</DOCNO>
	<brief_summary>Patients cystic fibrosis ( CF ) suffer chronic infection low respiratory tract cause one multiple bacteria , include Pseudomonas aeruginosa , particularly problematic eradicate implicate major cause morbidity mortality CF patient . Aerosol delivery antibiotic directly lung increase local concentration antibiotic site infection result improve antimicrobial effect compare systemic administration . Bacterial resistance current aerosol antibiotic treatment indicate need improved therapy treat CF patient pulmonary infection cause multi-drug resistant Pseudomonas aeruginosa bacteria . High concentration MP-376 deliver directly lung project antimicrobial effect even resistant organism reduce emergence resistant bacteria .</brief_summary>
	<brief_title>Safety , Pharmacokinetic Pharmacodynamic Study MP-376 Patients With Cystic Fibrosis</brief_title>
	<detailed_description>This trial single-blind , placebo-controlled , dose escalate cohort , single multi-dose , multi-center study evaluate safety , tolerability pharmacokinetic profile levofloxacin administer MP-376 , twice daily 14 day aerosol route CF patient .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>&gt; 16 year age Confirmed Diagnosis Cystic Fibrosis Positive sputum culture P. aeruginosa within past 6 month Patients able elicit FEV1 &gt; /= 40 % predict value screen Clinically stable evidence acute respiratory lower respiratory infection within 28 day prior dose Able reproducibly perform spirometry measurement able repeatedly produce sputum several hour Use nebulized systemic antibiotic within 4 week start study History hypersensitivity fluoroquinolones intolerance aerosol medication Uncontrolled diabetes abnormal renal function Tobacco use ( smoke ) last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>